Free Trial

Rep. Lisa C. McClain Sells Off Shares of Dolby Laboratories (NYSE:DLB)

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Representative Lisa C. McClain sold shares of Dolby Laboratories (NYSE:DLB) worth between $1,001 and $15,000 in a transaction disclosed on September 12th.
  • Dolby Laboratories recently reported a quarterly earnings per share (EPS) of $0.78, exceeding analysts' estimates of $0.72, with a year-over-year revenue increase of 9.2%.
  • The company declared a quarterly dividend of $0.33 per share, reflecting a 1.8% dividend yield, with a payout ratio of 48.35%.
  • Five stocks to consider instead of Dolby Laboratories.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Dolby Laboratories NYSE: DLB. In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Dolby Laboratories stock on August 4th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
  • Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
  • Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
  • Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
  • Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
  • Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
  • Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
  • Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
  • Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
  • Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.

Dolby Laboratories Stock Performance

Dolby Laboratories stock traded up $0.14 during mid-day trading on Tuesday, reaching $71.94. The company's stock had a trading volume of 373,861 shares, compared to its average volume of 431,908. Dolby Laboratories has a 12 month low of $68.24 and a 12 month high of $89.66. The business's 50 day simple moving average is $73.67 and its 200 day simple moving average is $75.38. The company has a market capitalization of $6.89 billion, a price-to-earnings ratio of 26.35 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The company had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company's quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, sell-side analysts expect that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories's payout ratio is currently 48.35%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DLB. Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 target price on the stock. Tigress Financial boosted their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Baird R W raised shares of Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Rosenblatt Securities reaffirmed a "buy" rating and set a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Finally, Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $95.75.

Check Out Our Latest Analysis on Dolby Laboratories

Insider Activity

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 39,875 shares of the stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the completion of the sale, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. This represents a 25.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president owned 70,435 shares of the company's stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 99,366 shares of company stock worth $7,352,963 over the last ninety days. Company insiders own 38.39% of the company's stock.

Institutional Trading of Dolby Laboratories

A number of hedge funds have recently made changes to their positions in DLB. Osaic Holdings Inc. increased its stake in shares of Dolby Laboratories by 165.8% in the second quarter. Osaic Holdings Inc. now owns 2,541 shares of the electronics maker's stock valued at $195,000 after buying an additional 1,585 shares during the period. Orion Porfolio Solutions LLC raised its stake in shares of Dolby Laboratories by 7.1% during the second quarter. Orion Porfolio Solutions LLC now owns 23,575 shares of the electronics maker's stock valued at $1,751,000 after acquiring an additional 1,555 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Dolby Laboratories by 1.0% during the second quarter. Thrivent Financial for Lutherans now owns 67,992 shares of the electronics maker's stock worth $5,050,000 after purchasing an additional 679 shares during the period. B. Riley Wealth Advisors Inc. bought a new stake in shares of Dolby Laboratories in the second quarter worth $206,000. Finally, State of Wyoming increased its holdings in Dolby Laboratories by 384.8% in the second quarter. State of Wyoming now owns 7,989 shares of the electronics maker's stock valued at $593,000 after purchasing an additional 6,341 shares during the period. 58.56% of the stock is owned by institutional investors and hedge funds.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.